These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22981924)

  • 1. Neutrophil dynamics after chemotherapy and G-CSF: the role of pharmacokinetics in shaping the response.
    Brooks G; Provencher G; Lei J; Mackey MC
    J Theor Biol; 2012 Dec; 315():97-109. PubMed ID: 22981924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil dynamics in response to chemotherapy and G-CSF.
    Zhuge C; Lei J; Mackey MC
    J Theor Biol; 2012 Jan; 293():111-20. PubMed ID: 22037060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel strategies for granulocyte colony-stimulating factor treatment of severe prolonged neutropenia suggested by mathematical modeling.
    Shochat E; Rom-Kedar V
    Clin Cancer Res; 2008 Oct; 14(20):6354-63. PubMed ID: 18927273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended activity in cynomolgus monkeys of a granulocyte colony-stimulating factor mutein conjugated with high molecular weight polyethylene glycol.
    Eliason JF; Greway A; Tare N; Inoue T; Bowen S; Dar M; Yamasaki M; Okabe M; Horii I
    Stem Cells; 2000; 18(1):40-5. PubMed ID: 10661570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and clinical correlates after chemotherapy and granulocyte colony-stimulating factor administration.
    Higa GM; DeVore RF; Auber ML; Lynch JP; Landreth KS
    Pharmacotherapy; 1998; 18(1):1-8. PubMed ID: 9469674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-CSF control of neutrophils dynamics in the blood.
    Shochat E; Rom-Kedar V; Segel LA
    Bull Math Biol; 2007 Oct; 69(7):2299-338. PubMed ID: 17554586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical model for G-CSF administration after chemotherapy.
    Foley C; Mackey MC
    J Theor Biol; 2009 Mar; 257(1):27-44. PubMed ID: 19007795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
    Ohnoshi T; Ueoka H; Kodani T; Kamei H; Kimura I
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):911-8. PubMed ID: 1693062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-CSF treatment of canine cyclical neutropenia: a comprehensive mathematical model.
    Colijn C; Foley C; Mackey MC
    Exp Hematol; 2007 Jun; 35(6):898-907. PubMed ID: 17533044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil growth factors.
    Crawford J
    Curr Hematol Rep; 2002 Nov; 1(2):95-102. PubMed ID: 12901130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose continuous subcutaneous infusion of granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in acute myelogenous leukemia and its pharmacokinetics.
    Ikeda K; Tasaka T; Sasaki K; Murata M; Kitanaka A; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1994 Nov; 8(11):1838-41. PubMed ID: 7526087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of a recombinant human granulocyte colony-stimulating factor.
    Kuwabara T; Kobayashi S; Sugiyama Y
    Drug Metab Rev; 1996 Nov; 28(4):625-58. PubMed ID: 8959393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia.
    Ho P; Sherman P; Grigg A
    Eur J Haematol; 2012 May; 88(5):416-21. PubMed ID: 22296221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant human granulocyte colony-stimulating factor on neutrophil function in vitro and in vivo following chemotherapy and autologous bone marrow transplantation.
    Humphreys JM; Rugman FP; Davies JM; Mimnagh P; Hart CA; Edwards SW
    J Clin Lab Immunol; 1991 Feb; 34(2):55-61. PubMed ID: 1725883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil dynamics during concurrent chemotherapy and G-CSF administration: Mathematical modelling guides dose optimisation to minimise neutropenia.
    Craig M; Humphries AR; Nekka F; BĂ©lair J; Li J; Mackey MC
    J Theor Biol; 2015 Nov; 385():77-89. PubMed ID: 26343861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.